Joana Correia, CEO and CSO of Exogenus Therapeutics is an invited speaker at the 2nd Exosome Based Therapeutic Development Summit, taking place during November 11-12 (online). Joana will be joined by other world leaders in exosome development to discuss the pains and gains of translating exosomes into clinical application. To hear more about Exogenus’ progress and future perspectives (November 12th, 3:30pm EST), register here and to find out more about the congress, program and fellow speakers, click here.